Current Position of High-resolution MS for Drug Quantification in Clinical & Forensic Toxicology
Overview
Affiliations
This paper reviews high-resolution MS approaches published from January 2011 until March 2014 for the quantification of drugs (of abuse) and/or their metabolites in biosamples using LC-MS with time-of-flight or Orbitrap™ mass analyzers. Corresponding approaches are discussed including sample preparation and mass spectral settings. The advantages and limitations of high-resolution MS for drug quantification, as well as the demand for a certain resolution or a specific mass accuracy are also explored.
Feliu C, Konecki C, Cazaubon Y, Binet L, Vautier D, Fouley A Pharmaceuticals (Basel). 2023; 16(1).
PMID: 36678573 PMC: 9865759. DOI: 10.3390/ph16010076.
Steuer A, Brockbals L, Kraemer T Front Chem. 2019; 7:319.
PMID: 31134189 PMC: 6523029. DOI: 10.3389/fchem.2019.00319.
Medication contaminants as a potential cause of anaphylaxis to vincristine.
Hill D, Leahy A, Sciasci J, ONeill S, Reilly A, Balamuth N Pediatr Blood Cancer. 2017; 65(1).
PMID: 28834048 PMC: 5978699. DOI: 10.1002/pbc.26761.
Rochat B J Am Soc Mass Spectrom. 2017; 28(4):709-723.
PMID: 28116700 DOI: 10.1007/s13361-016-1556-0.
Geib T, Sleno L, Hall R, Stokes C, Volmer D J Am Soc Mass Spectrom. 2016; 27(8):1404-10.
PMID: 27154021 DOI: 10.1007/s13361-016-1412-2.